UK GOVERNMENT WEIGHS PALANTIR NHS CONTRACT

Burnham previously blocked Palantir from operating in Greater Manchester, establishing himself as skeptical of the data analytics firm. Now leading the government, he must decide whether to extend that opposition nationally. The contract represents a significant foothold for the U.S. company within the NHS. Terminating it would demonstrate commitment to restricting foreign tech firms' access to sensitive health data. However, cancellation risks diplomatic friction with the U.S. and could deter other American technology investments in Britain. The decision reflects broader tensions between data security concerns and economic pragmatism. The NHS has increasingly relied on external technology partners, raising questions about oversight and data protection. Burnham's choice will set precedent for how the UK government balances public sector autonomy with international business relationships during a period of tech sector scrutiny.